News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Courtney Billington

Advertisement

President of Janssen Neuroscience, which provides treatments and services for adults living with serious mental illness

Articles by Courtney Billington

Restoring Hope in Mental Illness Is a Collective Mission

ByCourtney Billington
May 11th 2022

The importance of equitable approaches to diagnosis and treatment.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on PharmExec

    1

    Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade

    2

    Roundup: Pharma’s Funding Surge Ahead of J.P. Morgan 2026

    3

    Johnson & Johnson Reaches Agreement with Trump Administration, Continues $55 Billion US-Based Investment Plan

    4

    FDA Limits Regulations on Non-Medical Grade Wearable Fitness Devices

    5

    How is Re-Vana Using its Sustained-Delivery Hydrogel Technology to Position Itself as a Long-Term Partner at the 2026 J.P. Morgan Healthcare Conference?

    • About
    • Advertise
    • Contact Us
    • Editorial Board
    • Editorial Submission Guidelines
    • Do Not Sell My Personal Information
    • Privacy Policy
    • Terms and Conditions
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us